Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
MID Programs Provide Real-Time Patient Monitoring, Explains Dr Christie Smith
April 30th 2024The real-time monitoring of patients through medically integrated dispensing (MID) programs can reduce costs of care and remove barriers, said Christie Smith, PharmD, MBA, vice president, pharmacy and payer strategy, Cencora.
Read More
Just as it is important for retail analysts to understand the choices their customers make and why they may choose not to purchase a specific item, so is it important for the specialty pharmacy industry to understand the actions of prescribers and how the often inefficient prior authorization process affects patient outcomes.
Read More
Examining the IRA’s Impacts and the Differences of a Second Biden vs Trump Term at AXS24
April 26th 2024During their session at Asembia’s AXS24, Sarah Butler and Lindsay Greenleaf of ADVI Health will examine the current status of the Inflation Reduction Act (IRA) and future considerations in health care in the context of the upcoming presidential election.
Read More
Q&A: Elizabeth Johnson Shares Why Empathy Is Missing From Patient-Centered Care
May 12th 2023Elizabeth Johnson, LPN, PACS, BPCA, CEO of MedicoCX, co-CEO of Healthcare Advocate Summit, and an Asembia 2023 presenter, discusses why more empathetic approaches that take into account the full range of the patient experience are needed to improve patient-focused health care.
Read More
IQVIA’s Luke Greenwalt on Increasing Payer Pressures: We Can Change the Path We’re On
May 11th 2023“As we look over the next decade, the climb is going to be steep, it's going to be challenging, but success is still possible,” said Luke Greenwalt, vice president of market access at IQVIA, during his session at Asembia 2023.
Read More
Specialty Pharmacies Should Leverage AI Tracking to Increase Drug Delivery Efficiency
May 10th 2023Speakers at the 2023 Asembia Specialty Pharmacy Summit outlined how artificial intelligence (AI) tools for pharmaceuticals, such as parcel tracking, could reduce operational costs for specialty pharmacies and mitigate drug delivery issues for patients.
Read More
Removing the Taboo: Talking About Women’s Health Is the First Step to Improving Health Equity
May 9th 2023A panel on women’s health disparities at the 2023 Asembia Specialty Pharmacy Summit addressed the current challenges women face regarding health care as well as how digital tools, collaboration between clinics and governments, and more detailed and inclusive research can help improve health equity for all women.
Read More
Sebastian Pistritto: Harnessing Data Boosts Efficiency in Medication Delivery
May 4th 2023Sebastian Pistritto, chief marketing officer at ParcelShield Holdings, LLC, talks about how technology such as artificial intelligence helps to evaluate data to assist in medication delivery service decision-making, depending on the need of the pharmacy and its patients.
Read More
Julie Reed: The Status Quo for Biosimilars Needs to Change to Maintain the Industry
May 4th 2023The 2023 Asembia Specialty Pharmacy Summit featured Juliana (Julie) Reed, executive director of the Biosimilars Forum, who spoke on the challenges still facing the biosimilars industry and how they may impact the success of adalimumab biosimilars in the United States.
Read More
Cardinal Health's Naveen Mansukhani Details How Lowering Costs Is a Multi-Department Effort
May 3rd 2023Naveen Mansukhani, director of operations and account management of Retail Pharmacy Services at Cardinal Health, talks about how the responsibility for saving costs does not just fall on one department or person, but is collaborative and requires strategy.
Read More
NHIA's Connie Sullivan Discusses the Benefits and Patient Satisfaction of Home Infusion
May 3rd 2023Connie Sullivan, president and CEO of the National Home Infusion Association (NHIA), discusses why at-home infusion is beneficial to patients and why so many patients reported feeling satisfied with home administration.
Read More
Digital Tools May Help Improve Patient Experience, but Human Connection Is Still Needed
May 3rd 2023Although digital tools can be immensely helpful for creating a personalized, convenient interaction between patients and the health care system, they should not be the end-all be-all method to improve the patient experience, according to a panel discussion at the 2023 Asembia Specialty Pharmacy Summit.
Read More
Josh Marsh Discusses the Role of Technology, Automation in Patient Assistance Programs
May 2nd 2023Technology and automation within patient assistance programs can enhance the patient journey and assist pharmaceutical manufacturers at a lower cost, explained Josh Marsh, vice president of Sonexus at Cardinal Health.
Read More
Survey Shows Payers More Likely to Prefer Multiple Biosimilars for the Same Reference Product
May 2nd 2023In a panel at the 2023 Asembia Specialty Pharmacy Summit, speakers presented on the payer perspective regarding biosimilars, including that they feel comfortable preferring multiple biosimilars for the same reference product and are looking for interchangeability designations.
Read More
Payers, Drug Manufacturers Can Expect More Liability Under New IRA Drug Pricing Policies
May 2nd 2023Panelists at the 2023 Asembia Specialty Pharmacy Summit discussed the myriad of ways that the drug pricing policies of the Inflation Reduction Act (IRA), such as inflation rebates and a redesign of Medicare Part D plans, will affect payers and manufacturers.
Read More
Asembia 2023 Summit to Provide Insight Into Health Equity, IRA, and More
April 25th 2023Several presentations at the 2023 Asembia Specialty Pharmacy Summit, held in Las Vegas, Nevada, from April 30 through May 4, will cover how to address health equity concerns in specialty pharmacy care, the expansion of the biosimilars market, and the impact of the Inflation Reduction Act (IRA) on the US health care system.
Read More
Julie Reed Previews Biosimilar Session at Asembia 2023
April 25th 2023At Asembia 2023, there will be a call to action for participants to adjust their current business models and advocate for access to biosimilars with lower list costs, explained Julie Reed, executive director of the Biosimilars Forum.
Read More
Dr Sonia Oskouei Highlights the Need to Align Incentives to Promote Use of Biosimilars
May 27th 2022Alignment of incentives in the United States do not always support the use of biosimilars or other lower-cost alternatives, said Sonia T. Oskouei, PharmD, BCMAS, DPLA, vice president of biosimilars at Cardinal Health.
Read More